Evaluation of Substituted <i>N</i>-Phenylpiperazine Analogs as D3 vs. D2 Dopamine Receptor Subtype Selective Ligands
<i>N-</i>phenylpiperazine analogs can bind selectively to the D3 versus the D2 dopamine receptor subtype despite the fact that these two D2-like dopamine receptor subtypes exhibit substantial amino acid sequence homology. The binding for a number of these receptor subtype selective compo...
Main Authors: | Boeun Lee, Michelle Taylor, Suzy A. Griffin, Tamara McInnis, Nathalie Sumien, Robert H. Mach, Robert R. Luedtke |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2021-05-01
|
Series: | Molecules |
Subjects: | |
Online Access: | https://www.mdpi.com/1420-3049/26/11/3182 |
Similar Items
-
Chirality of Novel Bitopic Agonists Determines Unique Pharmacology at the Dopamine D3 Receptor
by: Pramisha Adhikari, et al.
Published: (2021-04-01) -
D2 dopamine receptor subtype-mediated hyperactivity and amphetamine responses in a model of ADHD
by: Xueliang Fan, et al.
Published: (2010-01-01) -
Striatal Distribution and Cytoarchitecture of Dopamine Receptor Subtype 1 and 2: Evidence from Double-Labeling Transgenic Mice
by: Keke Ren, et al.
Published: (2017-08-01) -
Phase 1 Parkinson’s Disease Studies Show the Dopamine D1/D5 Agonist PF-06649751 is Safe and Well Tolerated
by: U. Shivraj Sohur, et al.
Published: (2018-10-01) -
Basic evidence for class A G-protein-coupled receptor heteromerization
by: Rafael eFranco, et al.
Published: (2016-03-01)